Controlled release naproxen and naproxen sodium tablets

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 4803079
SERIAL NO

06811575

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled release tablet for once-daily oral administration of about 500-1200 mg of naproxen or naproxen sodium, said tablet comprising a homogeneous matrix comprising about 4-9 weight percent of hydroxypropyl methylcellulose having a number average molecular weight in the range of from about 80,000 to about 130,000, about 81-96 weight percent naproxen or naproxen sodium, and 0.1 to about 2 weight percent of a pharmaceutically acceptable lubricating agent, and optionally including a pharmaceutically acceptable coating.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (SPIL) THE CORNER HOUSE CHURCH STREET HAMILTON 5 BERMUDA A CORP OF BERMUDANot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hsiao, Charles H Cooper City, FL 7 316
Kent, John S Palo Alto, CA 16 1505

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation